Good to hear something from the company at least. Figures are improving but it is going to be a long haul back from being further underwater than a Gympie shopkeeper.
looks like they are on track to build the company out of the Labcon rubble.
The supply of consumables will make the company more attractive than selling the system and customers can work out how to get vials and other storage to read.
Could be the beginning of the turnaround?
We live in hope.
- Forums
- ASX - By Stock
- BCT
- Ann: Appendix 4D & Half Year Financial Report
Ann: Appendix 4D & Half Year Financial Report, page-2
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.616M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online